Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Yun Shao

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Oral Oncology|August 27, 2010
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaYu-Yun Shao, Ruey-Long Hong
Anticancer Research|November 27, 2008
Fatal thrombocytopenia after oxaliplatin-based chemotherapyYu-Yun Shao, Ruey-Long Hong
Liver Cancer|June 23, 2025
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical TrialsYu-Yun Shao, Andrei R Akhmetzhanov
Journal of Cancer Policy|April 30, 2026
Disparities in Medical Expenditure on Advanced Cancer Care in TaiwanTsung-Che Wu, Yu-Yun Shao
World Journal of Gastroenterology|October 1, 2015
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Cancer Medicine|June 16, 2023
Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database studyYi-Hsin Liang, Kuo-Hsing Chen, Yu-Yun Shao
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Discovery Medicine|July 1, 2010
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancerYu-Yun Shao, Chia-Chi Lin, Chih-Hsin Yang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 17, 2020
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanYu-Yun Shao, Shen-Yung Wang, Shi-Ming Lin, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Oral Oncology|August 27, 2010
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaYu-Yun Shao, Ruey-Long Hong
Anticancer Research|November 27, 2008
Fatal thrombocytopenia after oxaliplatin-based chemotherapyYu-Yun Shao, Ruey-Long Hong
Liver Cancer|June 23, 2025
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical TrialsYu-Yun Shao, Andrei R Akhmetzhanov
Journal of Cancer Policy|April 30, 2026
Disparities in Medical Expenditure on Advanced Cancer Care in TaiwanTsung-Che Wu, Yu-Yun Shao
World Journal of Gastroenterology|October 1, 2015
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Cancer Medicine|June 16, 2023
Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database studyYi-Hsin Liang, Kuo-Hsing Chen, Yu-Yun Shao
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Discovery Medicine|July 1, 2010
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancerYu-Yun Shao, Chia-Chi Lin, Chih-Hsin Yang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 17, 2020
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanYu-Yun Shao, Shen-Yung Wang, Shi-Ming Lin, et al.
Pageof 12